AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
17.75
-0.23 (-1.28%)
At close: Jan 8, 2026, 4:00 PM EST
17.99
+0.24 (1.35%)
After-hours: Jan 8, 2026, 4:58 PM EST
PSIL Holdings Information
PSIL is an equity ETF with a total of 30 individual holdings. The top holdings are AtaiBeckley stock at 12.01%, COMPASS Pathways at 8.91%, Supernus Pharmaceuticals at 7.65%, Mind Medicine (MindMed) at 7.60%, and Relmada Therapeutics at 7.13%.
Total Holdings
30
Top 10 Percentage
68.42%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
19.00M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | AtaiBeckley Inc. | 12.01% |
| 2 | CMPS | COMPASS Pathways plc | 8.91% |
| 3 | SUPN | Supernus Pharmaceuticals, Inc. | 7.65% |
| 4 | MNMD | Mind Medicine (MindMed) Inc. | 7.60% |
| 5 | RLMD | Relmada Therapeutics, Inc. | 7.13% |
| 6 | GHRS | GH Research PLC | 5.19% |
| 7 | CSE: DRUG | Bright Minds Biosciences Inc. | 5.07% |
| 8 | NRXP | NRx Pharmaceuticals, Inc. | 5.04% |
| 9 | NBIX | Neurocrine Biosciences, Inc. | 5.00% |
| 10 | ALKS | Alkermes plc | 4.82% |
| 11 | CYBN.NE | Cybin Inc Ordinary Shares | 3.99% |
| 12 | ANRO | Alto Neuroscience, Inc. | 3.95% |
| 13 | ABBV | AbbVie Inc. | 3.61% |
| 14 | JNJ | Johnson & Johnson | 3.42% |
| 15 | NEUP | Neuphoria Therapeutics Inc. | 2.92% |
| 16 | STIM | Neuronetics, Inc. | 2.51% |
| 17 | n/a | Blackrock Treasury Trust Instl 62 | 2.47% |
| 18 | CSE: QNTM | Quantum BioPharma Ltd. | 1.90% |
| 19 | KTTA | Pasithea Therapeutics Corp. | 1.80% |
| 20 | IXHL | Incannex Healthcare Inc. | 1.47% |
| 21 | SILO | Silo Pharma, Inc. | 1.25% |
| 22 | VTGN | Vistagen Therapeutics, Inc. | 0.99% |
| 23 | TSX: NUMI | Numinus Wellness Inc. | 0.85% |
| 24 | ENVB | Enveric Biosciences, Inc. | 0.36% |
| 25 | CMND | Clearmind Medicine Inc. | 0.10% |
As of Jan 6, 2026